|
RSS
Cancer Molecular Diagnostics: On The Critical Path To Personalized Medicine:The Healthcare practice at Frost & Sullivan is pleased to announce its 2008 Quarterly Analyst Briefing Presentation on the North American cancer molecular diagnostics market to be held on Thursday July 24, 2008 at 10:00 a.m. PDT. The presentation will cover strategic insight into the U.S. cancer molecular diagnostics market and how the market correlates with growth in the world of personalized medicine.
Plants Make Vaccine For Treating Type Of Cancer, Stanford Study:Plants could act as safe, speedy factories for growing antibodies for personalized treatments against a common form of cancer, according to new findings from the Stanford University School of Medicine. The findings came in the first human tests of an injectable vaccine grown in genetically engineered plants.
Research Identifies Best Way To Discover If Cancer Has Spread:For patients with head and neck cancer, accurately determining how advanced the cancer is and detecting secondary cancers usually means undergoing numerous tests - until now. New Saint Louis University research has found that the PET-CT scanner can be used as a stand-alone tool to detect secondary cancers, which occur in 5 to 10 percent of head and neck cancer patients.
Unnecessary Biopsies Reduced By Team Work, SLU Researchers Find:Unnecessary biopsies could be a thing of the past for patients undergoing treatment for head and neck cancer. New Saint Louis University research found that when nuclear medicine clinicians and treating physicians work together to interpret PET-CT scan results, the accuracy dramatically improves, sparring patients unnecessary pain and suffering.
NICE Drug Reviews Terminated When Manufacturers Fail To Submit Evidence, July 2008, UK:Because insufficient evidence was provided by the manufacturers, NICE is unable to recommend the use the following treatments in the NHS: -- bevacizumab in combination with paclitaxel for the first-line treatment of metastatic breast cancer -- bevacizumab in addition to platinu
Imaging System Offers Glimpse Of Rare Mutant Cells, May Help Understand Origins Of Cancer:MIT biological engineers have developed a new imaging system that allows them to see cells that have undergone a specific mutation. The work, which could help scientists understand how precancerous mutations arise, marks the first time researchers have been able to pinpoint the number and location of mutant cells - cells with a particular mutation - in intact tissue. In this case, the researchers worked with mouse pancreatic cells.
Rexahn Pharmaceuticals Receives U.S. Patent For New Cancer Compounds:Rexahn Pharmaceuticals, Inc. (AMEX:RNN), a, leader in innovative therapeutics for life-threatening and life-debilitating diseases, today announced that the U.S. Patent & Trademark Office has issued to the Company U.S. Patent 7,388,014, entitled "Quinazoline Derivatives and Therapeutic Use Thereof.
Researchers Study Causes Of Malignancy:The South is known for many things hot, steamy summers, iced tea laced with sugar and friendly people with a tendency to welcome strangers. But beneath the veneer of Southern hospitality and gracious living lurks a silent killer cancer. Vanderbilt-Ingram Cancer Center researchers have their own name for the southern region of the United States The Cancer Belt.
Once Suspect Protein Found To Promote DNA Repair, Prevent Cancer:An abundant chromosomal protein that binds to damaged DNA prevents cancer development by enhancing DNA repair, researchers at The University of Texas M. D. Anderson Cancer Center report online this week in the Proceedings of the National Academy of Sciences. The protein, HMGB1, was previously hypothesized to block DNA repair, senior author Karen Vasquez, Ph.D., associate professor in M. D.
Precancerous Esophagus Disease Eliminated In 98.4% Of Patients Treated With HALO Ablation System:BARRX Medical, Inc. announced that 98.4 percent of patients having a precancerous condition of their esophagus called Barrett's esophagus were free of the disease 2.5 years after non-surgical, endoscopic treatment with the HALO ablation system. The results were published this month in Gastrointestinal Endoscopy, a leading scientific publication for gastrointestinal physicians and researchers.
|
|
|
